EUCTR2011-001505-26-SE进行中(未招募)1 期
Repeated doses of misoprostol for medical treatment of missed abortion
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 899,991
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Patients with missed abortion with visible fetal structures without progress in time or stable or sinking levels of s-hcg, over 18 years of age and in good general health, opting for medical treatment and willing to participate in the study will be included.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with an empty gestational sac, more than a sparse ongoing bleeding or cervical dilation as signs of ongoing miscarriage, mental instability after the diagnosis or any contraindication to medical treatment such as bleeding disorder or contraindication to any medication given during medical treatment will be excluded
研究者
相似试验
已完成
不适用
Misoprostol administered sublingually for second trimester pregnancy terminatioAbortionInduced abortionPregnancy and ChildbirthISRCTN72965671DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction680
已完成
3 期
A clinical trial to study the effects of mifepristone and misoprostol given at same time for abortion.CTRI/2010/091/001422I100
招募中
4 期
TWO DOSES OF MIFEPRISTONE FOLLOWED BY MISOPROSTOL FOR MEDICAL TERMINATION OF PREGNANCY IN THE SECOND TRIMESTERCTRI/2017/12/010862PGIMER
已完成
3 期
The effect of misoprostol and oxytocin in the treatment of placenta retainingRelation the effects of misoprostol and oxytocin in the treatment of placenta.IRCT2015102824754N1Tehran University of Medical Sciences44
已完成
不适用
The effect of misoprostol with folley catheter (traction) & Rising induction in second trimester terminatioIRCT201103146066N1Vice chancellor for research, Hamedan University of Medical Sciences72
